Jen Rito

Jen Rito has extensive work experience in the pharmaceutical industry, with a focus on clinical operations. Jen currently holds the position of Sr. Director of Clinical Operations at Aligos Therapeutics, starting in March 2023. Prior to that, they served as the Director of Clinical Operations at the same company from March 2021 to February 2023.

Before joining Aligos Therapeutics, Jen Rito worked at Tolerion, Inc. as the Sr. Director of Clinical Operations from March 2020 to March 2021. Jen also held the role of Director of Clinical Operations at Denali Therapeutics from July 2019 to March 2020.

Jen Rito's earlier experience includes a position as Director of Clinical Operations at Janssen BioPharma, Inc. (formerly Alios) from September 2017 to July 2019. Before that, they worked as an Associate Director of Clinical Operations at Alios BioPharma from April 2015 to August 2017.

In addition, Jen Rito has gained valuable experience in clinical project management and study management, having worked as a Sr. Clinical Operations Manager/Clinical Project Manager at Medivation from March 2011 to April 2015, and as a Global Clinical Study Manager at Facet Biotech from March 2008 to March 2011.

Earlier in their career, Jen Rito held roles at PDL BioPharma as a Sr. Manager of Clinical Site Monitoring from September 2007 to March 2008, and at Protein Design Labs, Inc. as a Sr. Clinical Study Manager/Clinical Study Manager/Sr. CRA from 2001 to 2007.

Jen began their career as a Sr. CRA at Covance from 1998 to 2000.

Jen Rito holds a Bachelor of Science in Nursing (BSN) from California State University - Hayward. The specific dates of their education are not provided.